Australia-based Telix Pharmaceuticals has announced that the United States (US) Food and Drug Administration (FDA) has a...
US-based Thermo Fisher Scientific has introduced the Thermo Scientific™ Heratherm™ Environmental Chambe...
Indian biopharma firm Biocon has announced the signing of partnership agreement with Bahiafarma and Bionovis for Pe...
Nipro Corporation, a global healthcare and medical technology company, has announced the establishment of its Asia Pacif...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that...
Viral Vector Manufacturing Facility (VVMF), Australia’s first viral vector Contract Development and Manufacturing ...
Novo Holdings, a leading global healthcare and life sciences investor, has announced a strategic minority investment in ...
Korea Advanced Institute of Science and Technology (KAIST) has partnered with Thermo Fisher Scientific to establish SHAR...
Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In it...
US-based Waters Corporation has announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analys...
Japan-based Shionogi has received marketing authorisation from the Therapeutic Goods Administration (TGA) in Australia f...
South Korea-based Classys, a global player in medical aesthetics, has stepped into India, through its partnership with P...
Taiwan-based Horien Biochemical Technology has announced a major double milestone in its global expansion strategy, i.e....
US-based Thermo Fisher Scientific has announced the launch of the Thermo Scientific Multiskan Ease Absorbance Microplate...
ENA Respiratory, a clinical-stage pharmaceutical startup developing host defence enhancers for the prevention of complic...
Japan-based Ono Pharmaceutical has entered into a drug discovery partnership agreement with US-based Aitia, Inc. Under t...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
South Korea-based Samsung Bioepis has announced the marketing approval of Ustekinumab BS Intravenous Infusion 130mg...
South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Medtronic, a global leader in healthcare technology, has announced a strategic partnership with Hong Kong based startup ...
Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to...
Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that th...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has anno...
